Table 2.
Age and sex distribution of all glomerulonephritis (without minimal change disease) over the 2 year period 2012–2013
| 2012–2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 0–4 | 5–14 | 15–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65+ | Total (male) |
| FSGS | 12 7 M |
19 9 M |
26 16 M |
27 15 M |
21 8 M |
13 8 M |
7 6 M |
3 3 M |
135 (53%) |
| MGN | 1 M |
2 2 M |
10 5 M |
19 9 M |
19 6 M |
11 6 M |
5 1 M |
4 3 M |
71 (46%) |
| SLE | 4 1 M |
12 3 M |
16 0 M |
12 2 M |
6 2 M |
1 0 M |
51 (16%) |
||
| IGAN | 1 0 M |
6 2 M |
4 1 M |
7 7 M |
4 3 M |
3 2 M |
2 1 M |
1 M |
28 (61%) |
| Crescentic GN | 2 1 M |
6 3 M |
5 1 M |
5 4 M |
3 1 M |
2 1 M |
3 3 M |
26 (54%) |
|
| MPGN | 4 3 M |
3 2 M |
2 1 M |
1 M |
2 2 M |
12 (75%) |
|||
| PSGN | 8 7 M |
1 0 M |
1 M |
10 (80%) |
|||||
| other GN | 2 1 M |
1 0 M |
4 1 M |
5 3 M |
4 3 M |
1 M |
1 M |
18 (56%) |
|
| CGN-NOS ESRD | 1 M |
4 2 M |
3 M |
10 9 M |
5 3 M |
1 M |
24 (71%) |
||
| HUS | 4 3 M |
1 0 M |
1 0 M |
1 0 M |
2 2 M |
9 (55%) |
|||
| Total GN | 24 10 M |
50 27 M |
71 33 M |
93 46 M |
71 29 M |
39 21 M |
20 13 M |
16 14 M |
384 (50%) |
Abbreviations: M male, FSGS focal segmental glomerulosclerosis, MGN membranous glomerulonephritis (GN), MPGN membranoproliferative GN, IGAN immunoglobulin A nephropathy, PSGN post-streptococcal GN, SLE lupus nephritis, CGN ESRD chronic GN not otherwise specified at end-stage renal disease, HUS hemolytic uremic syndrome